CR Failure, RA Stenosis - Annals of Internal Medicine, 2008 - Am Coll Physicians T he current Update in Nephrology reviews the most important recent articles relevant to those
practicing nephrology. The Table summarizes changes to clinical practice that should emerge
from these articles. ... Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat ... Related articles
S Pasquali, L Cagnoli, C Rovinetti, A Rigotti, P … - … International journal of …, 1985 - ncbi.nlm.nih.gov Nineteen patients with severe renal failure due to multiple myeloma and with Bence Jones proteinuria
greater than 1 gm/day were randomly assigned to group I or group II. Corticosteroids and cytotoxic
drugs were given to all cases. The 9 patients of group I were also treated by peritoneal ... Cited by 11 - Related articles
K Tsunemi, M Hida, Y Takebayashi, J … - Therapeutic …, 1993 - books.google.com 296 K. Tsunemi et al. Talik-1. Oinical and laboratory data, therapy and follow up Case Age
Sex-type RIP S-Cr TP Hb Alb MOF Stage (mg/dl)(g/dl)(g/dl)(g/dl) number Med. HD PE Outcome
frequency (month) 1 65 M IgG Af 3.6 13.4 8.9 2.3 4 III BP, MI 2 D< 1 2 55 M IgG A+ 14.6 ... Cited by 1 - Related articles
OB Jennifer, JC Maize, RF Woolson, MN Budisavljevic - J Med, 2007 - njmonline.nl In a past issue, Wetzels1 advises to avoid gadolinium-based contrast agents in patients with
stage 4 and 5 kidney disease, ie a GFR <30 ml/min. His advice is in line with the opinion of many
more authors and guidelines, such as the one proposed by the Netherlands Federation of ... Related articles - View as HTML - All 2 versions
MA Gertz - Leukemia & Lymphoma, 2007 - informahealthcare.com The management of renal failure in patients with newly-diagnosed multiple myeloma remains
an ongoing challenge for practicing clinicians. In this issue of Leukemia and Lymphoma, the
Greek Myeloma Study Group reports an incidence of renal failure at presentation of 21%, ... Cited by 14 - Related articles - BL Direct - All 7 versions
C da Costa Leite - SciELO Brasil O alerta da Food and Drug Administration (FDA) (http://www.fda.gov/bbs/topics/NEWS/2007/NEW01638
.html), em junho de 2006, sobre a fibrose nefrogênica sistêmica (FNS)/fibrose cutânea sistêmica
obriga-nos a rever os nossos conceitos de segurança do gadolínio. Depois do RSNA de ... Related articles - Cached - All 2 versions
CC Leite - Radiologia Brasileira, 2007 - SciELO Brasil Up to some time ago, we radiologists have been using gadolinium in patients affected by renal
insuffi- ciency, and this was done very confidently, with assur- ance that we were utilizing a safe
alternative for assess- ment of these patients. The Food and Drug Administration (FDA) ... Related articles - View as HTML
C da Costa Leite - SciELO Brasil Up to some time ago, we radiologists have been using gadolinium in patients affected by renal
insuffi- ciency, and this was done very confidently, with assur- ance that we were utilizing a safe
alternative for assess- ment of these patients. The Food and Drug Administration (FDA) ... Related articles - View as HTML
C IIa - Springer Ce texte (édité en 2007, revu en 2008) est un résumé des recom- mandations publiées « Guidelines
for the management of patients with per- ipheral arterial disease » développé par l'ACC/AHA
task force, adopté par le CIRSE et publié en 2006 (1, 2). Les lecteurs doivent se référer à ... Related articles
